CN Patent

CN114588156B — 一种眼用制剂及其在治疗老花眼中的应用

Assigned to Eye Hospital of Wenzhou Medical University · Expires 2024-06-11 · 2y expired

What this patent protects

本发明公开了一种眼用制剂及其在治疗老花眼中的应用，所述眼用制剂中包括醋可立定和瑞巴派特，本发明首次发现并证实了醋可立定和瑞巴派特联合具有协同增效的作用，瑞巴派特能够增强醋可立定的作用并减少相关副作用，醋可立定能够有效地与瑞巴派特产生协同效应收缩瞳孔括约肌，所述眼用制剂能够有效改善、减轻或治疗老花眼，同时具有潜在延缓老化眼病程进展作用，具有非常好的临床应用前景。

USPTO Abstract

本发明公开了一种眼用制剂及其在治疗老花眼中的应用，所述眼用制剂中包括醋可立定和瑞巴派特，本发明首次发现并证实了醋可立定和瑞巴派特联合具有协同增效的作用，瑞巴派特能够增强醋可立定的作用并减少相关副作用，醋可立定能够有效地与瑞巴派特产生协同效应收缩瞳孔括约肌，所述眼用制剂能够有效改善、减轻或治疗老花眼，同时具有潜在延缓老化眼病程进展作用，具有非常好的临床应用前景。

Drugs covered by this patent

Patent Metadata

Patent number: CN114588156B
Jurisdiction: CN
Classification: —
Expires: 2024-06-11
Drug substance claim: No
Drug product claim: No
Assignee: Eye Hospital of Wenzhou Medical University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.